These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 7748483)

  • 1. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
    Frei B
    Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE; Schwenke DC; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxidized low density lipoprotein in atherogenesis.
    Jialal I; Devaraj S
    J Nutr; 1996 Apr; 126(4 Suppl):1053S-7S. PubMed ID: 8642431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits.
    Shaish A; Daugherty A; O'Sullivan F; Schonfeld G; Heinecke JW
    J Clin Invest; 1995 Oct; 96(4):2075-82. PubMed ID: 7560102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation.
    Naderi GA; Asgary S; Sarraf-Zadegan N; Shirvany H
    Mol Cell Biochem; 2003 Apr; 246(1-2):193-6. PubMed ID: 12841362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development.
    Aviram M; Kaplan M; Rosenblat M; Fuhrman B
    Handb Exp Pharmacol; 2005; (170):263-300. PubMed ID: 16596803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse.
    Crawford RS; Kirk EA; Rosenfeld ME; LeBoeuf RC; Chait A
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1506-13. PubMed ID: 9743241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-tocopherol preserves endothelial cell migration in the presence of cell-oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity.
    van Aalst JA; Burmeister W; Fox PL; Graham LM
    J Vasc Surg; 2004 Jan; 39(1):229-37. PubMed ID: 14718844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lipoprotein lipid oxidation.
    Cynshi O; Stocker R
    Handb Exp Pharmacol; 2005; (170):563-90. PubMed ID: 16596815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M; Dornfeld L; Kaplan M; Coleman R; Gaitini D; Nitecki S; Hofman A; Rosenblat M; Volkova N; Presser D; Attias J; Hayek T; Fuhrman B
    Drugs Exp Clin Res; 2002; 28(2-3):49-62. PubMed ID: 12224378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oxidative modification of low density lipoprotein by human lymphocytes.
    Lamb DJ; Wilkins GM; Leake DS
    Atherosclerosis; 1992 Feb; 92(2-3):187-92. PubMed ID: 1632847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.
    Aviram M; Fuhrman B
    Mol Cell Biochem; 1998 Nov; 188(1-2):149-59. PubMed ID: 9823020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies.
    Albertini R; Moratti R; De Luca G
    Curr Mol Med; 2002 Sep; 2(6):579-92. PubMed ID: 12243250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D; Parthasarathy S; Carew TE
    Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis.
    Heinecke JW
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1261-4. PubMed ID: 11498450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.